Company intelligence / Profile preview

Virco

Mechelen, Belgium

Ownership: Private
Development stage: Other

Overview

Virco was a diagnostics company founded in 1995 that specialized in HIV treatment diagnostic services (notably the Antivirogram test). The company was acquired by Johnson & Johnson in 2002 for $320 million and ceased to exist as an independent entity, becoming integrated into Johnson & Johnson's operations.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic services
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Virco.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virco.

Explore the full profile